Terms: = Thyroid cancer AND PTCH1, RP11-435O5_3, Q13635, PTCH, 5727, HPE7, FLJ26746, NBCCS, BCNS, PTC1, ENSG00000185920, FLJ42602 AND Prognosis
13 results:
1. TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling.
Zhu R; Gires O; Zhu L; Liu J; Li J; Yang H; Ju G; Huang J; Ge W; Chen Y; Lu Z; Wang H
Nat Commun; 2019 Jun; 10(1):2863. PubMed ID: 31253779
[TBL] [Abstract] [Full Text] [Related]
2. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
Kure S; Wada R; Naito Z
Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
[TBL] [Abstract] [Full Text] [Related]
3. Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.
Fulciniti F; Barizzi J; Trimboli P; Giovanella L
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659000
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract] [Full Text] [Related]
5. The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution.
Ieni A; Barresi V; Cardia R; Licata L; Di Bari F; Benvenga S; Tuccari G
Rev Endocr Metab Disord; 2016 Dec; 17(4):521-527. PubMed ID: 27896649
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Alterations in Differentiated thyroid cancer Patients with Acromegaly.
Aydin K; Aydin C; Dagdelen S; Tezel GG; Erbas T
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):198-202. PubMed ID: 26575115
[TBL] [Abstract] [Full Text] [Related]
7. miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
Minna E; Romeo P; De Cecco L; Dugo M; Cassinelli G; Pilotti S; Degl'Innocenti D; Lanzi C; Casalini P; Pierotti MA; Greco A; Borrello MG
Oncotarget; 2014 May; 5(9):2513-28. PubMed ID: 24810336
[TBL] [Abstract] [Full Text] [Related]
8. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
Wang P; Wang YG; Zhao WJ; Fu YD; Wang L; Wang F; Zhao SH
Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
[TBL] [Abstract] [Full Text] [Related]
9. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
[TBL] [Abstract] [Full Text] [Related]
10. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
Rodrigues R; Roque L; Espadinha C; Pinto A; Domingues R; Dinis J; Catarino A; Pereira T; Leite V
Oncol Rep; 2007 Oct; 18(4):917-26. PubMed ID: 17786355
[TBL] [Abstract] [Full Text] [Related]
11. Temporal trends and clinical correlates for the ret/ptc1 mutation in papillary thyroid carcinoma.
Burgess JR; Skabo S; McArdle K; Tucker P
ANZ J Surg; 2003; 73(1-2):31-5. PubMed ID: 12534735
[TBL] [Abstract] [Full Text] [Related]
12. Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome.
Kjellman P; Learoyd DL; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson BG; Zedenius J
Br J Surg; 2001 Apr; 88(4):557-63. PubMed ID: 11298625
[TBL] [Abstract] [Full Text] [Related]
13. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection.
Cetta F; Olschwang S; Petracci M; Montalto G; Baldi C; Zuckermann M; Mariani Costantini R; Fusco A
World J Surg; 1998 Dec; 22(12):1231-6. PubMed ID: 9841749
[TBL] [Abstract] [Full Text] [Related]
